| Literature DB >> 36188983 |
Tijana Simic1,2, Laura Laird3,4, Nadia Brisson5, Kathy Moretti5, Jean-Luc Théorêt5, Sandra E Black2,4,6,7, Gail A Eskes2,8, Carol Leonard2,3,5, Elizabeth Rochon2,3,4,7.
Abstract
Persons with aphasia (PWA) often have deficits in cognitive domains such as working memory (WM), which are negatively correlated with recovery, and studies have targeted WM deficits in aphasia therapy. To our knowledge, however, no study has examined the efficacy of multi-modal training which includes both WM training and targeted language therapy. This pilot project examined the feasibility and preliminary efficacy of combining WM training and naming therapy to treat post-stroke PWA. Chronic PWA were randomly assigned to either the a) Phonological Components Analysis (PCA) and WM intervention (WMI) condition (i.e., a computerized adaptive dual n-back task), or b) PCA and active control condition (WMC). Participants received face-to-face PCA therapy 3 times/week for 5 weeks, and simultaneously engaged in WM training or the active control condition five times/week, independently at home. Six PWA were enrolled, 3 in each condition. Feasibility metrics were excellent for protocol compliance, retention rate and lack of adverse events. Recruitment was less successful, with insufficient participants for group analyses. Participants in the WMI (but not the WMC) condition demonstrated a clinically significant (i.e., > 5 points) improvement on the Western Aphasia Battery- Aphasia Quotient (WAB-R AQ) and Boston Naming Test after therapy. Given the small sample size, the performance of two individuals, matched on age, education, naming accuracy pre-treatment, WAB-R AQ and WM abilities was compared. Participant WMI-3 demonstrated a notable increase in WM training performance over the course of therapy; WMC-2 was the matched control. After therapy, WMI-3's naming accuracy for the treated words improved from 30 to 90% (compared to 30-50% for WMC-2) with a 7-point WAB-R AQ increase (compared to 3 for WMC-2). Improvements were also found for WMI-3 but not for WMC-2 on ratings of communicative effectiveness, confidence and some conversation parameters in discourse. This feasibility study demonstrated excellent results for most aspects of Co-TrEAT. Recruitment rate, hampered by limited resources, must be addressed in future trials; remotely delivered aphasia therapy may be a possible solution. Although no firm conclusions can be drawn, the case studies suggest that WM training has the potential to improve language and communication outcomes when combined with aphasia therapy.Entities:
Keywords: anomia; aphasia; multi-modal therapy; rehabilitation; working memory
Year: 2022 PMID: 36188983 PMCID: PMC9397805 DOI: 10.3389/fresc.2022.815780
Source DB: PubMed Journal: Front Rehabil Sci ISSN: 2673-6861
Individual participant characteristics.
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|
| WMI-1 | Intervention | M | 59 | 14 | 1.25 | Anomic |
| WMI-2 | Intervention | M | 59 | 18 | 4 | Anomic |
| WMI-3 | Intervention | F | 53 | 21 | 0.75 | Conduction |
| WMC-1 | Control | M | 75 | 14 | 6 | Broca's |
| WMC-2 | Control | M | 59 | 16 | 3.5 | Anomic |
| WMC-3 | Control | M | 50 | 14 | 1 | Broca's |
| 59.2 (8.6) | 16 (2.9) | 2.83 (2.1) | ||||
| 57 (3.5) | 17.7 (3.5) | 2 (1.8) | ||||
| 61.3 (12.7) | 14.7 (1.2) | 3.5 (2.5) |
All participants had a single left-hemisphere cerebrovascular accident and were premorbidly right-handed.
Percent naming accuracy of treated and untreated words for each individual participant, across the three baseline periods, and at post-treatment and follow-up.
|
|
|
|
|
|
| ||
|---|---|---|---|---|---|---|---|
|
| |||||||
| Intervention | WMI-1 | 0.00 | 6.67 | 16.67 | 7.78 | 26.67 | 30.00 |
| WMI-2 | 16.67 | 6.67 | 20.00 | 14.44 |
| 46.67 | |
| WMI-3 | 10.00 | 10.00 | 16.67 | 12.22 |
|
| |
| Control | WMC-1 | 10.00 | 26.67 | 6.67 | 14.44 |
|
|
| WMC-2 | 33.33 | 13.33 | 3.33 | 16.67 | 46.67 | 53.33 | |
| WMC-3 | 3.33 | 0.00 | 0.00 | 1.11 |
|
| |
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
| |
|
| |||||||
| Intervention | WMI-1 | 3.33 | 0.00 | 10.00 | 4.44 | 10.00 | 13.33 |
| WMI-2 | 16.67 | 6.67 | 13.33 | 12.22 | 16.67 | 30.00 | |
| WMI-3 | 0.00 | 6.67 | 26.67 | 11.11 | 30.00 | 60.00 | |
| Control | WMC-1 | 13.33 | 16.67 | 6.67 | 12.22 | 30.00 | 23.33 |
| WMC-2 | 20.00 | 3.33 | 26.67 | 16.67 |
| 46.67 | |
| WMC-3 | 0.00 | 0.00 | 3.33 | 1.11 | 16.67 |
| |
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
| |
Significant WEST-ROC and WEST-Trend result, based on one-sample t-tests (one-tailed). Bonferroni-corrected for multiple comparisons (i.e., alpha = 0.05/4 = 0.013). Note. WEST weighting factors are based on three baseline measures and one post-therapy measure (i.e., either post-treatment, or 4r-week follow-up). B1, Baseline 1; B2, Baseline 2; B3, Baseline 3; 4WFU, 4-week follow-up.
Individual participant scores on measures of anomia and aphasia severity, communicative effectiveness and confidence, WM and discourse comprehension across assessment times.
|
|
| |||||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
| |
|
| ||||||||
| Pre | 76.8 | 81.1 | 79.4 |
| 66.2 | 77.6 | 43.6 |
|
| Post | 85.2 | 82.5 | 85.7 |
| 72.2 | 77.2 | 49.0 |
|
| 1-month | 84.6 | 92.9 | 85.7 |
| 76.6 | 81.3 | 40.9 |
|
|
| ||||||||
| Pre | 13.3 | 38.3 | 40.0 |
| 65.0 | 55.0 | 15.0 |
|
| Post | 15.0 | 46.7 | 60.0 |
| 63.3 | 53.3 | 25.0 |
|
| 1-month | 11.7 | 46.7 | 68.3 |
| 60.0 | 56.7 | 16.7 |
|
|
| ||||||||
| Pre | 52.4 | 82.4 | 46.4 |
| 47.5 | 65.3 | 54.3 |
|
| Post | 57.4 | 64.0 | 83.5 |
| 49.2 | 63.5 | 76.6 |
|
| 1-month | 41.5 | 83.8 | 79.5 |
| 53.4 | 73.1 | 43.2 |
|
|
| ||||||||
| Pre | 47.8 | 71.0 | 61.6 |
| 46.1 | 60.9 | 77.6 |
|
| Post | 52.7 | 64.7 | 80.5 |
| n/a | n/a | 69.4 |
|
| 1-month | 57.1 | 63.1 | 91.2 |
| 53.1 | n/a | 71.3 |
|
|
| ||||||||
| Pre | 57.5 | 72.5 | 65.0 |
| 60.0 | 75.0 | 60.0 |
|
| Post | 60.0 | 77.5 | 90.0 |
| 60.0 | 75.0 | 67.5 |
|
| 1-month | 52.5 | 82.5 | 72.5 |
| 65.0 | 72.5 | 60.0 |
|
| Pre | 8 | 7 | 0 |
| 4 | 8 | 0 |
|
| Post | 5 | 7 | 3 |
| 4 | 8 | 0 |
|
| 1-month | 8 | 8 | 2 |
| 5 | 7 | 1 |
|
| Pre | 4 | 3 | 2 |
| 2 | 3 | 1 |
|
| Post | 5 | 3 | 4 |
| 3 | 3 | 0 |
|
| 1-month | 4 | 3 | 4 |
| 2 | 4 | 3 |
|
| Pre | 10 | 5 | 8 |
| 6 | 5 | 5 |
|
| Post | 9 | 7 | 8 |
| 7 | 9 | 7 |
|
| 1-month | 11 | 7 | 9 |
| 6 | 10 | 4 |
|
| Pre | 7 | 7 | 6 |
| 7 | 7 | 7 |
|
| Post | 8 | 5 | 9 |
| 6 | 7 | 6 |
|
| 1-month | 8 | 6 | 10 |
| 10 | 8 | 6 |
|
|
| ||||||||
| Pre | 92.5 | 92.5 | 77.5 |
| 75.0 | 77.5 | 65.0 |
|
| Post | 70.0 | 95.0 | 82.5 |
| 82.5 | 90.0 | 60.0 |
|
| 1-month | 90.0 | 90.0 | 87.5 |
| 72.5 | 75.0 | 52.5 |
|
CETI score not available (not completed accurately).
Conversational speech analysis using POWERS parameters and associated ratios across participants and assessment times.
|
|
| |||||
|---|---|---|---|---|---|---|
|
|
|
|
|
|
| |
|
| ||||||
| Pre | 0.27 | 0.24 | 0.19 | 0.4 | 0.13 | 0.44 |
| Post | 0.15 | 0.33 | 0.19 | 0.57 | - | 0.4 |
| 1-month | 0.08 | 0.29 | 0.2 | 0.61 | 0.31 | 0.52 |
|
| ||||||
| Pre | 0.22 | 0.06 | 0.12 | 2 | 0.39 | 0.19 |
| Post | 0.05 | 0.17 | 0.26 | 1.47 | - | 0.07 |
| 1-month | 0.23 | 0.15 | 0.28 | 0.89 | 0.28 | 0.1 |
|
| ||||||
| Pre | 0.67 | 0.15 | 0.76 | 1.59 | 0.89 | 0.31 |
| Post | 0.2 | 0.49 | 3.33 | 0.49 | - | 0.08 |
| 1-month | 1.34 | 0.44 | 4.48 | 0.21 | 0.52 | 0.12 |
|
| ||||||
| Pre | 4.31 | 4.19 | 8.2 | 1.97 | 3.2 | 3.22 |
| Post | 5.45 | 4.54 | 19.82 | 1.3 | - | 1.95 |
| 1-month | 7.13 | 4.43 | 19.9 | 1.13 | 4.32 | 2.77 |
|
| ||||||
| Pre | 1.11 | 1.33 | 1.4 | 1.41 | 1.92 | 0.7 |
| Post | 1.26 | 0.98 | 2.24 | 0.87 | - | 0.64 |
| 1-month | 2.06 | 1.62 | 4.1 | 0.92 | 1.26 | 1 |
Post-treatment speech sample not available for WMC-2. All scores represent ratios based on POWERS conversational parameters [as per (.